Skip to content

Indole-benzimidazole hybrids modulate lipid metabolism and promote autophagic and apoptotic signaling in breast cancer.

Sep 2026 · Naunyn-Schmiedeberg's Archives of Pharmacology · 0 citations · 52 references
Medicine

TL;DR

The findings demonstrate that indole-benzimidazole hybrids function as multifunctional modulators of breast cancer cell metabolism by coordinately targeting lipid homeostasis, sphingolipid-associated signaling, autophagic regulation, and apoptosis.

View source

Similar papers

Review Sep 2026

Lipid Metabolic Reprogramming in Colorectal Cancer: A Central Hub Integrating Diet, Microenvironment, and Therapy Resistance.

Colorectal cancer (CRC), a significant malignancy of the digestive system, represents a considerable threat to global health. Currently, its clinical efficacy is often limited by tumor heterogeneity and therapeutic resistance. Lipid metabolic reprogramming has been identified as a core process in CRC, not only providin...

Xiao-Ya Zong, Wei-Bing Zu, Dong Tang · 0 citations
Review Open access Oct 2026

Salidroside Regulates Energy Metabolism Reprogramming to Suppress Tumor Proliferation: Mechanisms and Therapeutic Implications

Salidroside, a phenylethanol glycoside and principal bioactive constituent of Rhodiola rosea, has emerged as a promising multi-target anti-tumor agent with significant effects on cancer energy metabolism. This review summarizes and analyzes the mechanisms it uses to reprogram tumor energy metabolism. Recent studies sho...

Hao-Lin Wang, Yu-Xin Du · 0 citations
Open access Oct 2026

Effects of a Benzimidazolium Salt on Colorectal Cancer Cells: Involvement of Apoptosis and Autophagy

Colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide, necessitating the identification of novel small molecules capable of targeting multiple survival pathways. In this study, the antiproliferative potential of dds benzimidazole-palladium (Pd) complexes was evaluated across breast cance...

Mustafa Çakır, E. Acikgoz, B. Kuzu et al. · 0 citations
Oct 2026

Icariin synergistically inhibits glycolysis and mitochondrial energy metabolism in lung cancer in association with the HIF-1α/LONP1 axis.

AIM OF THE STUDY Non-small cell lung cancer (NSCLC) accounts for the vast majority of lung cancer cases and remains a therapeutic challenge due to drug resistance, adverse effects, and metabolic plasticity. Icariin (ICR), a principal bioactive flavonoid from Epimedium, exhibits promising antitumor properties; however,...

Hong-Bo Zheng, Bo-Jia Li, Jun-Lei Chen et al. · 0 citations
Review Open access Sep 2026

Metabolic modulators as gatekeepers of immunotherapy response in colorectal cancer

Colorectal cancer (CRC) continues to pose a significant global health concern, largely driven by metabolic reprogramming mechanisms that facilitate tumor progression and enable immune evasion within the tumor microenvironment (TME). This review highlights the pivotal functions of dysregulated metabolic pathways, such...

Alireza Najafi, Ali Rahimi, Zeinab Baghernejadian et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.